- Home
- ESBA vs HCM Comparison
ESBA vs HCM Comparison
Compare ESBA & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESBA
- HCM
- Stock Information
- Founded
- ESBA N/A
- HCM 2000
- Country
- ESBA United States
- HCM Hong Kong
- Employees
- ESBA N/A
- HCM N/A
- Industry
- ESBA
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- ESBA
- HCM Health Care
- Exchange
- ESBA NYSE
- HCM Nasdaq
- Market Cap
- ESBA 2.2B
- HCM 2.5B
- IPO Year
- ESBA 2013
- HCM N/A
- Fundamental
- Price
- ESBA N/A
- HCM $13.76
- Analyst Decision
- ESBA
- HCM Hold
- Analyst Count
- ESBA 0
- HCM 1
- Target Price
- ESBA N/A
- HCM $19.00
- AVG Volume (30 Days)
- ESBA 5.8K
- HCM 128.4K
- Earning Date
- ESBA 01-01-0001
- HCM 03-19-2025
- Dividend Yield
- ESBA 2.02%
- HCM N/A
- EPS Growth
- ESBA N/A
- HCM N/A
- EPS
- ESBA 0.28
- HCM 0.04
- Revenue
- ESBA $763,152,000.00
- HCM $630,201,000.00
- Revenue This Year
- ESBA N/A
- HCM $28.98
- Revenue Next Year
- ESBA N/A
- HCM $20.41
- P/E Ratio
- ESBA $24.91
- HCM $63.68
- Revenue Growth
- ESBA 3.19
- HCM N/A
- 52 Week Low
- ESBA $6.39
- HCM $11.51
- 52 Week High
- ESBA $11.50
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- ESBA 35.45
- HCM 46.20
- Support Level
- ESBA $6.70
- HCM $13.50
- Resistance Level
- ESBA $7.07
- HCM $15.11
- Average True Range (ATR)
- ESBA 0.27
- HCM 0.66
- MACD
- ESBA 0.03
- HCM -0.00
- Stochastic Oscillator
- ESBA 40.14
- HCM 45.69
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.